Considerable scale-up is needed to achieve the 2025 goals for HIV pre-exposure prophylaxis (PrEP), according to study findings.

SAN DIEGO, Dec. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak® ...

A recent phase 3 trial found that twice-yearly injections of Lenacapavir reduce the risk of contracting HIV by 96%. | Drug ...

Cidara Therapeutics (CDTX) announced it has reached full planned enrollment of 5,000 subjects in the Phase 2b NAVIGATE trial across clinical ...

For oral medications that prevent new HIV infection to be effective, the patient must take certain actions, including ...

THE United States Agency for International Development (USAID) has partnered with the private sector for more locally accessible, stigma-free and lifesaving HIV services. The country has one of the ...

Elections have consequences, and HIV/AIDS advocates are worried about potential cuts as Republicans take over both houses of ...

Even though HIV is just one of a vast number of viruses that infect people, there can still be a stigma surrounding it. To ...

DIRECTOR General of the National Agency for the Control of AIDS (NACA), Dr Temitope llori has said that HIV infection in ...

The Department of Health Western Visayas is intensifying its call for increased testing for human immunodeficiency virus (HIV ...

The new incurable disease hit all the taboos in Malaysian society as it was linked to drug use and sex. Being in the drug ...

The Royal Pharmaceutical Society (RPS) has warned about “patient safety” after discovering that draft HIV guidance directs ...